Navigation Links
ReShape Medical Appoints Robert E. Grant to Board of Directors
Date:6/21/2012

SAN CLEMENTE, Calif., June 21, 2012 /PRNewswire/ -- ReShape Medical, a company focused on a non-surgical weight loss device, announced today that Robert E. Grant will join its board of directors.

(Photo:  http://photos.prnewswire.com/prnh/20120621/LA28274)

Grant currently serves as chairman of Strathspey Crown LLC, a growth equity firm in Newport Beach focusing on lifestyle healthcare and cash-pay medical products. He is former president of the medical aesthetics division at Allergan Inc. in Irvine and most recently served as chief executive officer and president of Bausch+Lomb Surgical in Aliso Viejo. He brings extensive experience leading global medical device and pharmaceutical organizations.

"Robert is a visionary leader and strategist and we are delighted that he is joining the team," said Richard Thompson, ReShape Medical president and CEO. "His expertise with cash-pay, elective medical procedures will be invaluable as we move toward commercialization."  ReShape Medical is preparing to begin a pivotal clinical study to gain approval in the U.S. and launched commercially in Europe earlier this year.

Grant said, "I strongly believe there is a huge market opportunity for non-surgical weight loss devices and also that ReShape Medical is well positioned to be the market leader. I am honored to be joining the talented and experienced ReShape board."    

In addition to Grant, ReShape Medical's board of directors consists of: Ken Charhut (Chairman), President and CEO of Mindframe Inc.; Jeani Delagardelle, Managing Director of New Leaf Venture Partners; Casey Tansey, General Partner at US Venture Partners; David Milne, Managing Partner at SV Life Sciences; George Wallace, Managing General Partner for Intersect Partners LLC; and Richard Thompson, President and CEO of ReShape Medical.

About ReShape Medical, Inc.
ReShape Medical® is a medical device manufacturer headquartered in Southern California. The company specializes in a dual-intragastric balloon for weight loss, ReShape Duo®, to be used as an aid in the treatment of obese or overweight patients. ReShape Duo is a non-surgical alternative designed for those who have exhausted their efforts with diet alone and wish to avoid or do not qualify for surgery. It comfortably occupies existing space in the stomach for six months, serving as built in portion control, to help patients feel full and satisfied with less food. CAUTION - Limited by United States law to investigational use.


'/>"/>
SOURCE ReShape Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical (AVACEN) ... is now successfully helping those with the widespread pain ... Fibromyalgia diagnosed Amanda in Essex, England ... washing my hair, experiencing no sleep at all, tremendous ... spasm… I cannot recommend [the AVACEN 100] enough, how ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
Breaking Medicine News(10 mins):